Published

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmacology & therapeutics
Date: 2019-05-01
Source: PubMed
DOI: 10.1016/j.pharmthera.2018.11.010
PubMed: 30521880

Authors

Johnson MW Hendricks PS Barrett FS Griffiths RR

Watch author

Derived topics and classifications

psilocybin Depression Addiction End-of-Life Distress Brain Imaging Mechanism of Action Receptor Pharmacology Consciousness Aging Mystical Experience Review Article Healthy Volunteers Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin2026-04-10

Related papers

Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-07-01 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.Pharmacology research & perspectives · 2026-04-01 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01